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(IC)detector making use of gamma analysis (3%,3mm): 
measurement and simulationtimes were compared too. 
 
Results: The table shows a comparison of clinically 
significant DVH points from TPS dose distribution, MC 
simulation of the nominal plan and of TCS log file. 
 
 
In figure a comparison of TPS and MC planar dose distribution 
with 2DQA measurements is shown. In our protocol, if the 
passing rate (PR) is above 95% the field is accepted. If it is 
between 95 and 90% a justification must be added to the QA 
report to flag the field as accepted. A passing rate below 90% 
makes the field unacceptable. In the graph 27 fields 
belonging to 10 patients are analysed. MC has a PR always 
greater than 95% for every depth showing a good agreement 
with measurements. TPS results are always in the “grey” area 
between 90 and 95%. The execution time of a 2DQA with an 
array of ICs takes almost 1 hour and half; simulations, that 
can be performed in parallel, take 11 minutes on average. 
 
 
 
Conclusion: We realized a system to verify with an 
independent calculation algorithm both the nominal plan and 
the delivered one with the TPS dose distribution. This lets 
the user to estimate the effects on the dose distribution due 
to a different algorithm and due to delivery uncertainties of 
the machine. We proposed a method to drastically reduce 
2DQA verification time. Our suggestion is to substitute 
measurements with simulation that showed a very high 
accordance in terms of gamma PR (always above 95%); one 
field per patient may be measured at single depth as an 
additional safety check.  
[1] F Fracchiolla et al,'End to end' validation of a Monte Carlo 
code for independent dose calculation in a proton pencil 
beam scanning system Radand Onc, 115, S78–S79, 2015 
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Purpose or Objective: The treatment couches for Gantry2 
will support new head pieces for head and neck treatments, 
the BoS HeadframeTM. Thanks to their geometry and 
composition (a sandwich of thin carbon layers and light 
foam), they will increase the flexibility of planning, as they 
should only minimally disturb proton beams passing through 
it. Therefore there will be no restrictions in the deliverable 
gantry angles; posterior targets will be treated in supine 
position, thus increasing patient comfort, safety (especially 
for children under anesthesia) and the position accuracy (bite 
block will be used more often). We describe here the 
measurement of their Water Equivalent Range (WER) and 
homogeneity. 
 
Material and Methods: Mono-energetic scanned proton layers 
(12x20cm2) of 129 MeV up to 145 MeV were delivered through 
the head support, with the proton dose on exit being 
measured using a scintillating screen/CCD camera device 
approach. A reference set of measurements were first 
performed without the head support with 1 MeV discrete 
energy steps. The measurements were then repeated for 
three different positions (head, neck and shoulder) of the 
head support. A second set of measurements were performed 
with an energy step of 0.2 MeV for energies between 133-139 
MeV, to increase the measurement accuracy. For each 
acquisition, a 2D map of the maximum values among all the 
layers was generated, from which the WER of the head 
support in the different positions could be calculated by 
subtracting the measurements with and without the frame. 
WER homogeneity was calculated as the standard deviation of 
sub-regions of the 2D difference maximum value maps. CT 
images of the head supports were also imported in the TPS 
and converted to WER (via HU-Relative Proton Stopping 
Power calibration curve), to estimate if the planned WER 
corresponded to the measured values (with no need of 
synthetic CTs). 
 
Results: WER was found to be between 2.4mm and 7.2mm 
with an accuracy of 1.0mm or 0.5mm, depending on the 
measurements energy steps (respectively 1.0 MeV and 0.2 
MeV) (Fig). In the three different positions, WER in-
homogeneity was lower than 1.0mm (respectively 0.36mm, 
0.99mm and 0.40mm). The differences of WER between 
measured and TPS values were also below 0.5 mm (0.2 MeV 
step) and 1.4 mm (1 MeV step). 
 
 
 
Conclusion: The described method was accurate, fast and 
reproducible. The results on the thickness and homogeneity 
of the head frame show that it can be safely and accurately 
used in clinical operation and the first patients have already 
been treated. 
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Purpose or Objective: Accurate modeling of the MLC is 
necessary to achieve a clinically acceptable agreement 
between dose calculations and measurements in IMRT/VMAT 
treatment plans. The RayStation TPS uses several parameters 
to model a MLC but no specific procedure exists on how to 
perform measurements to optimize them. The aim of this 
work is to present a fast procedure to optimize the MLC 
parameters in RayStation v.4.5 and to assess the obtained 
MLC model. 
 
Material and Methods: A proper set of MLC-collimated fields 
was designed on a Varian Trilogy linear accelerator equipped 
with a Millennium 120 MLC. Dose profile scans of those fields 
